Skip to main content
Przejdź do strony domowej Komisji Europejskiej (odnośnik otworzy się w nowym oknie)
polski pl
CORDIS - Wyniki badań wspieranych przez UE
CORDIS

mapping the sequence determinants of protein stability and its contribution to rare genetic diseases

Cel

Missense variants cause nearly one-third of all human genetic diseases, yet most have unknown functional consequences. Computational predictors can flag pathogenic variants, but they remain blind to mechanism—whether a mutation destabilizes a protein, mislocalizes it, or alters its interactions. Without mechanism, variant interpretation is incomplete and therapeutic opportunities remain hidden. I previously developed deep mutational scanning (DMS) methods to quantify the effects of >500,000 variants on the stability of >500 human protein domains, revealing that ~50% of pathogenic variants destabilize proteins. Yet this still covers barely 1% of domains and 2% of unique folds in human. Most of the proteome—including most rare disease proteins—remains experimentally unexplored.
Here, we will expand this approach to decode how protein stability is encoded in sequence and how its loss contributes to rare genetic diseases. Specifically, we will:

1) Chart the landscape of protein fold stability — generating the broadest DMS survey of fold space to date, covering 800 unique folds to uncover the sequence determinants of stability and refine predictive models.
2) Expand stability mapping to full-length proteins in human cells — by generating DMS maps across 500 rare disease proteins, we will reveal how mutations in domains, linkers, and disordered regions shape protein abundance in cells, and test the specificity of stabilizer drugs.
3) Dissect how the proteostasis network shapes disease variant outcomes —by systematically mapping how chaperones and degradation pathways interact with mutations, we will reveal variants whose effects emerge under proteostasis decline.

These datasets will serve as reference atlases for clinical variant interpretation across rare diseases— defining which are ‘folding diseases’, and which pathogenic variants are destabilizing—and collectively transform our understanding of how protein stability—and its failure—is encoded in the human genome.

Dziedzina nauki (EuroSciVoc)

Projekt nie został jeszcze sklasyfikowany według klasyfikacji EuroSciVoc.
Wskaż dziedziny nauki, które twoim zdaniem są najbardziej istotne z punktu widzenia tego projektu i pomóż nam usprawnić naszą usługę klasyfikacji.

Słowa kluczowe

Program(-y)

Temat(-y)

System finansowania

HORIZON-ERC - HORIZON ERC Grants

Wyświetl wszystkie projekty finansowane w ramach tego programu finansowania

Zaproszenie do składania wniosków

(odnośnik otworzy się w nowym oknie) ERC-2026-STG

Wyświetl wszystkie projekty finansowane w ramach tego zaproszenia

Instytucja przyjmująca

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
Wkład UE netto
€ 1 625 000,00
Koszt całkowity
€ 1 625 000,00

Beneficjenci (1)